Leveraging Innovation To Deliver Precision Medicines

News & Events

Press Releases

Jubilant Therapeutics Inc to participate and present at upcoming Investor Conferences

BEDMINSTER, New Jersey – Nov 10, 2021 – Jubilant Therapeutics Inc., a private biopharmaceutical company advancing small molecule precision therapeutics to address unmet medical needs in oncology and autoimmune diseases, today announced that its senior management team led by Syed Kazmi, Chief Executive Officer will participate in one-one-one meetings and present at the following investor conferences:

    • Jefferies London Healthcare Conference

Date: Thursday, November 18th and Friday, November, 19th, 2021 (virtual)

    • Piper Sandler Annual Healthcare Conference 2021

Date: Monday, November 29th, 2021 (virtual)

We use cookies to recognize your repeat visits and preferences, as well as to measure the effectiveness
of campaigns and analyze traffic. If you continue to use this site we will assume your acceptance.